These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 14557482)
1. The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-beta. Luo X; Xu J; Chegini N J Clin Endocrinol Metab; 2003 Oct; 88(10):4967-76. PubMed ID: 14557482 [TBL] [Abstract][Full Text] [Related]
2. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells. Luo X; Xu J; Chegini N Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567 [TBL] [Abstract][Full Text] [Related]
3. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. Xu J; Luo X; Chegini N J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129 [TBL] [Abstract][Full Text] [Related]
4. Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells. Kim MR; Park DW; Lee JH; Choi DS; Hwang KJ; Ryu HS; Min CK Mol Hum Reprod; 2005 Nov; 11(11):801-8. PubMed ID: 16403803 [TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells. Luo X; Ding L; Chegini N Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E991-E1001. PubMed ID: 15265761 [TBL] [Abstract][Full Text] [Related]
6. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Mori Y; Chen SJ; Varga J Exp Cell Res; 2000 Aug; 258(2):374-83. PubMed ID: 10896788 [TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC; de Caestecker MP; Schnaper HW Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488 [TBL] [Abstract][Full Text] [Related]
8. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Chegini N; Luo X; Ding L; Ripley D Mol Cell Endocrinol; 2003 Nov; 209(1-2):9-16. PubMed ID: 14604812 [TBL] [Abstract][Full Text] [Related]
9. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the transforming growth factor-beta/Smad signaling pathway in the epithelium of oral lichen. Karatsaidis A; Schreurs O; Axéll T; Helgeland K; Schenck K J Invest Dermatol; 2003 Dec; 121(6):1283-90. PubMed ID: 14675171 [TBL] [Abstract][Full Text] [Related]
13. Activation of TGF-beta-Smad signaling pathway following polyamine depletion in intestinal epithelial cells. Liu L; Santora R; Rao JN; Guo X; Zou T; Zhang HM; Turner DJ; Wang JY Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1056-67. PubMed ID: 12855402 [TBL] [Abstract][Full Text] [Related]
14. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Yanagisawa K; Osada H; Masuda A; Kondo M; Saito T; Yatabe Y; Takagi K; Takahashi T; Takahashi T Oncogene; 1998 Oct; 17(13):1743-7. PubMed ID: 9796704 [TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Mori Y; Chen SJ; Varga J Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691 [TBL] [Abstract][Full Text] [Related]
17. Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture. Zhao J; Lee M; Smith S; Warburton D Dev Biol; 1998 Feb; 194(2):182-95. PubMed ID: 9501027 [TBL] [Abstract][Full Text] [Related]
18. Deficient Smad7 expression: a putative molecular defect in scleroderma. Dong C; Zhu S; Wang T; Yoon W; Li Z; Alvarez RJ; ten Dijke P; White B; Wigley FM; Goldschmidt-Clermont PJ Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3908-13. PubMed ID: 11904440 [TBL] [Abstract][Full Text] [Related]
19. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]